Stay updated on Fostamatinib in wAIHA Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in wAIHA Clinical Trial page.
Latest updates to the Fostamatinib in wAIHA Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.4.3 is now displayed on the page, replacing Revision: v3.4.2.SummaryDifference0.0%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2; no study data, eligibility criteria, or page functionality appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check43 days agoChange DetectedRevision: v3.4.1 is now displayed, replacing v3.4.0 (a minor site update). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check50 days agoChange DetectedShow glossary option was added. The page metadata was updated to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', and it removed the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.1%
- Check64 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. The update does not affect the study details or other information shown on the page.SummaryDifference0.0%
- Check87 days agoChange DetectedDifference1%
Stay in the know with updates to Fostamatinib in wAIHA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in wAIHA Clinical Trial page.